tirzepatide updates trial shows additional 21.1% weight loss following intensive lifestyle intervention Tirzepatide vs. Dulaglutide: Cardiovascular Outcomes

The strongest results in trials were seen after 6 months, 12 months and beyond

Thank you for your continued mentorship and I've gotten so much from this from you, over the years, and I appreciate you

The Nature Medicine substudy from the 48 week obesity trial assessed mean relative change in liver fat at 24 weeks in participants with metabolic dysfunction associated steatotic liver disease and elevated baseline liver fat, showing how the programme is being explored beyond weight alone using imaging based metrics

Dose adjustments or alternative management strategies may be necessary

The first and most obvious factor is the benzyl alcohol concentration

The experimental weight-loss drug, currently being developed by Eli Lilly and Company, has generated widespread excitement following clinical trial results showing participants lost an average of 28% of their body weight over 80 weeks at the highest dose studied